KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Invested Capital (2016 - 2025)

Gilead Sciences' Return on Invested Capital history spans 17 years, with the latest figure at 0.19% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 17.0% year-over-year to 0.19%; the TTM value through Dec 2025 reached 0.19%, up 17.0%, while the annual FY2025 figure was 0.19%, 16.0% up from the prior year.
  • Return on Invested Capital reached 0.19% in Q4 2025 per GILD's latest filing, up from 0.19% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.19% in Q4 2025 to a low of 0.01% in Q3 2024.
  • Average Return on Invested Capital over 5 years is 0.12%, with a median of 0.13% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: surged 33bps in 2021, then fell -13bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.15% in 2021, then dropped by -19bps to 0.12% in 2022, then rose by 6bps to 0.13% in 2023, then tumbled by -80bps to 0.03% in 2024, then skyrocketed by 633bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Return on Invested Capital are 0.19% (Q4 2025), 0.19% (Q3 2025), and 0.16% (Q2 2025).